Befejeződött1. fázis
A double-blind, placebo-controlled, parallel-group study to evaluate the safety and efficacy of briquilimab in participants with allergic asthma.
Key facts
- Where
- Grosshansdorf, Hanover és Mainz, NémetországSee the 3 sites
- Phase
- 1. fázis
Where in Németország
- Velocity Clinical Research Grosshansdorf GmbHGrosshansdorf, NémetországNo longer taking part
- The Fraunhofer Institute For Toxicology And Experimental Medicine ITEMHanover, NémetországNo longer taking part
- IKF Pneumologie GmbH & Co. KGMainz, NémetországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Jasper Therapeutics Inc.
- Trial code
- EU 2024-516164-28-00
- Record updated
- 2024. november 7.